Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).
Mitrovic Z, Dujmovic D, Jaksic O, Kinda SB, Gacina P, Perisa V, Prka Z, Dreta B, Galusic D, Holik H, Pejsa V, Aurer I. Mitrovic Z, et al. Among authors: pejsa v. Eur J Haematol. 2023 Jun;110(6):725-731. doi: 10.1111/ejh.13957. Epub 2023 Apr 2. Eur J Haematol. 2023. PMID: 36941738
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkin's lymphoma patients.
Lucijanić M, Huzjan Korunić R, Ivić M, Fazlić Džankić A, Jonjić Ž, Mitrović Z, Prka Ž, Piršić M, Jakšić O, Gaćina P, Vlasac Glasnović J, Pejša V. Lucijanić M, et al. Among authors: pejsa v. Wien Klin Wochenschr. 2022 Jan;134(1-2):80-82. doi: 10.1007/s00508-021-01850-x. Epub 2021 Apr 9. Wien Klin Wochenschr. 2022. PMID: 33835267
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases.
Galusic D, Basic-Kinda S, Pijuk A, Milunovic V, Dreta B, Franjic N, Coha B, Sincic-Petricevic J, Gacina P, Pejsa V, Lucijanic M, Aurer I. Galusic D, et al. Among authors: pejsa v. Hemasphere. 2022 Nov 15;6(12):e807. doi: 10.1097/HS9.0000000000000807. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36407092 Free PMC article.
The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis.
Lucijanic M, Pejsa V, Jaksic O, Mitrovic Z, Tomasovic-Loncaric C, Stoos-Veic T, Prka Z, Pirsic M, Haris V, Vasilj T, Kusec R. Lucijanic M, et al. Among authors: pejsa v. Acta Haematol. 2016;136(2):98-100. doi: 10.1159/000445247. Epub 2016 May 18. Acta Haematol. 2016. PMID: 27189016 Free article. No abstract available.
50 results